A case series of ziprasidone overdoses

Veterinary and Human Toxicology

Volumn 45, Issue 2, 2003, Pages 81-82

  Bryant, Sean M ^a   Zilberstein, Jeff ^b   Cumpston, Kirk L ^a   Magdziarz, Dan D ^c   Costerisan, Dennis ^d  

^a Jr Hospital of Cook County   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d St Marys Hospital Decatur   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; MAGNESIUM SULFATE; METHADONE; NEUROLEPTIC AGENT; OPIATE; PARACETAMOL; QUETIAPINE; ZIPRASIDONE;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; DRUG DEPENDENCE; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; QT INTERVAL; SCHIZOPHRENIA; SOMNOLENCE; SUICIDAL BEHAVIOR;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; OVERDOSE; PIPERAZINES; THIAZOLES;

EID: 0037347380     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Borison RL: Recent advances in the pharmacotherapy of schizophrenia. Harvard Rev Psychiatry 4:255-271, 1997.
2. Carnahan RM, Lund BC, Perry PJ: Ziprasidone, A new atypical antipsychotic drug. Pharmacotherapy 21:717-730, 2001.
3. Litovitz TL, Klein-Schwartz W, Rodgers GC et al: 2001 Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Amer Journ of Emerg Med 20:391-452, 2002.
4. Haddad PM, Anderson IM: Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62:1649-1671, 2002.
5. FDA, Psychopharmacological Drugs Advisory Committee: Briefing Document for Zeldex Capules (ziprasidone hydrochloride). URL: http:// www.fda.gov/ohrms/dockets/ac/00/backgrd/3619b1a.pdf. July 19, 2000.
6. FDA, Psychopharmacological Drugs Advisory Committee. Background on Zeldex (ziprasidone hydrochloride capsules) Pfizer Inc (online). URL: http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3619b1b.pdf. July 19, 2000.
7. Burton S, Heslop K, Harrison K et al: Ziprasidone overdoes. Amer Journ Psychiatry 157: 835, 2000.
8. House M: Overdose of ziprasidone. Amer Journ Psychiatry 159:1061-1062, 2002.
9. Lackey G, Alsop J, Albertson T: A one-year review of pediatric ziprasidone ingestions. Journ Toxicol Clin Toxicol 40:624, 2002.
10. Lackey G, Alsop J, Albertson T: Ziprasidone: A 12-month review of acute overdoses. Journ Toxicol Clin Toxicol 40:686, 2002.
11. Beelen AP, Yeo K-TJ, Lewis LD: Asymptomatic QTc prolongation associated with quetiapine fumurate overdose in a patient being treated with risperidone. Hum Exper Toxicol 20:215-219, 2001.
12. Burns MJ: The pharmacology and toxicology of atypical antipsychotic agents. Clin Toxicol 39:1-14, 2001.